Applied DNA Sciences Inc. (APDN)
NASDAQ: APDN
· Real-Time Price · USD
2.88
-0.05 (-1.71%)
At close: Sep 04, 2025, 3:59 PM
2.88
0.00%
After-hours: Sep 04, 2025, 07:53 PM EDT
-1.71% (1D)
| Bid | 2.83 |
| Market Cap | 1.49M |
| Revenue (ttm) | 3.3M |
| Net Income (ttm) | -37.11M |
| EPS (ttm) | -57.12 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -0.04 |
| Analyst | n/a |
| Ask | 2.89 |
| Volume | 48,468 |
| Avg. Volume (20D) | 126,009 |
| Open | 2.90 |
| Previous Close | 2.93 |
| Day's Range | 2.82 - 2.90 |
| 52-Week Range | 2.81 - 1410.00 |
| Beta | 0.07 |
About APDN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APDN
Website n/a
Next Earnings Release
Applied DNA Sciences Inc. is scheduled to release its earnings on
Dec 16, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+9.07%
Applied DNA Sciences shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago
-36.86%
Applied DNA Sciences shares are trading lower after the company announced a 1-for-15 reverse stock split.
3 weeks ago · accessnewswire.com
Applied DNA Reports Third Quarter Fiscal 2025 Financial ResultsSTONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production so...
2 months ago · accessnewswire.com
Applied DNA Regains Compliance with All Nasdaq Continued Listing RequirementsSTONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received w...
2 months ago · accessnewswire.com
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. HaywardPresident and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or...
